These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 11788817)

  • 21. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
    Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
    Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical role of FDG PET in evaluation of cancer patients.
    Kostakoglu L; Agress H; Goldsmith SJ
    Radiographics; 2003; 23(2):315-40; quiz 533. PubMed ID: 12640150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
    Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK
    J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indications for the use of PET or PET/CT in patients with breast cancer].
    Bernsdorf M; Graff J
    Ugeskr Laeger; 2011 Oct; 173(42):2638-41. PubMed ID: 22027163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET.
    Reinhardt MJ; Ehritt-Braun C; Vogelgesang D; Ihling C; Högerle S; Mix M; Moser E; Krause TM
    Radiology; 2001 Mar; 218(3):776-82. PubMed ID: 11230656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
    Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography for the diagnosis of breast cancer.
    Rosé C; Dose J; Avril N
    Nucl Med Commun; 2002 Jul; 23(7):613-8. PubMed ID: 12089482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current and future uses of positron emission tomography in breast cancer imaging.
    Eubank WB; Mankoff DA
    Semin Nucl Med; 2004 Jul; 34(3):224-40. PubMed ID: 15202103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer.
    Gil-Rendo A; Zornoza G; García-Velloso MJ; Regueira FM; Beorlegui C; Cervera M
    Br J Surg; 2006 Jun; 93(6):707-12. PubMed ID: 16622900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma.
    Bender H; Kirst J; Palmedo H; Schomburg A; Wagner U; Ruhlmann J; Biersack HJ
    Anticancer Res; 1997; 17(3B):1687-92. PubMed ID: 9179219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings.
    Crowe JP; Adler LP; Shenk RR; Sunshine J
    Ann Surg Oncol; 1994 Mar; 1(2):132-40. PubMed ID: 7834438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear medicine advances in breast cancer imaging.
    Bombardieri E; Crippa F; Baio SM; Peeters BA; Greco M; Pauwels EK
    Tumori; 2001; 87(5):277-87. PubMed ID: 11765174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.
    Dehdashti F; Mortimer JE; Siegel BA; Griffeth LK; Bonasera TJ; Fusselman MJ; Detert DD; Cutler PD; Katzenellenbogen JA; Welch MJ
    J Nucl Med; 1995 Oct; 36(10):1766-74. PubMed ID: 7562040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging role of PET in the diagnosis and staging of lung cancer.
    Coates G; Skehan SJ
    Can Respir J; 1999; 6(2):145-52. PubMed ID: 10322097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a role for positron emission tomography in breast cancer staging?
    Hodgson NC; Gulenchyn KY
    J Clin Oncol; 2008 Feb; 26(5):712-20. PubMed ID: 18258978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability.
    Scheidhauer K; Scharl A; Pietrzyk U; Wagner R; Göhring UJ; Schomäcker K; Schicha H
    Eur J Nucl Med; 1996 Jun; 23(6):618-23. PubMed ID: 8662094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
    Schmidt GP; Baur-Melnyk A; Haug A; Heinemann V; Bauerfeind I; Reiser MF; Schoenberg SO
    Eur J Radiol; 2008 Jan; 65(1):47-58. PubMed ID: 18082989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolving role of positron emission tomography in breast cancer imaging.
    Eubank WB; Mankoff DA
    Semin Nucl Med; 2005 Apr; 35(2):84-99. PubMed ID: 15765372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.